Actively Recruiting

Phase Not Applicable
Age: 45Years - 75Years
All Genders
NCT05123963

Restoring 24-hour Substrate Rhythmicity to Improve Glycemic Control by Timing of Lifestyle Factors

Led by Université de Sherbrooke · Updated on 2026-05-11

48

Participants Needed

1

Research Sites

328 weeks

Total Duration

On this page

Sponsors

U

Université de Sherbrooke

Lead Sponsor

U

University of Calgary

Collaborating Sponsor

AI-Summary

What this Trial Is About

Exercise is well-known to improve skeletal muscle energy metabolism and is an established intervention to improve muscle insulin sensitivity and to counter the development of type 2 diabetes (T2D). However, given the 24h rhythmicity in substrate metabolism previously observed in healthy, lean men and the lack of such rhythmicity in men with insulin-resistance, the investigator hypothesize that appropriate timing of exercise training can maximize the metabolic health effects of exercise. Indeed, a preliminary study in humans revealed that afternoon high-intensity interval training (HIIT) exercise was more effective than morning exercise in improving 24h blood glucose levels in men with T2D. Another recent study in mice showed that the time of day is a critical factor in augmenting the beneficial effects of exercise on the skeletal muscle metabolome as well as on whole-body energy homeostasis. However, human studies that specifically target the impact of timing of exercise training on glucose homeostasis and metabolic health are scarce and the potential underlying mechanisms largely unknown. The overarching goals of this project is to improve 24-hour rhythmicity of metabolism in men and women with prediabtes by appropriate timing of exercise and to assess its effect on metabolic health and immune response. Acute and prolonged exercise interventions timed in the morning vs late afternoon will be carried out in individuals with prediabetes to determine whether acute exercise in the afternoon and prolonged exercise training in the afternoon can improve peripheral insulin sensitivity, compared to exercise in the morning, and positively affect adipose tissue dietary fatty acid storage and partitioning of dietary fatty acids in skeletal muscles.

CONDITIONS

Official Title

Restoring 24-hour Substrate Rhythmicity to Improve Glycemic Control by Timing of Lifestyle Factors

Who Can Participate

Age: 45Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosed with prediabetes based on fasting plasma glucose 6.1 to 6.9 mmol/L, or 2-hour plasma glucose after 75g glucose tolerance test 7.8 to 11.0 mmol/L, or HbA1c 6.0 to 6.4%, or insulin resistance with glucose clearance rate 360 ml/kg/min.
  • Body mass index (BMI) greater than 25 kg/m2.
  • Willing and able to follow the study procedures.
  • Signed informed consent indicating understanding and willingness to participate.
Not Eligible

You will not qualify if you...

  • Known cardiovascular disease or abnormal ECG.
  • Taking medications affecting lipid or carbohydrate metabolism except statins (must stop 3 weeks prior), metformin or anti-hypertensive drugs (must stop 7 days prior).
  • Liver or kidney disease other than uncomplicated NASH or mild proteinuria.
  • Uncontrolled thyroid disorders.
  • Severe uncontrolled high blood pressure (systolic 180 mm Hg or diastolic 110 mm Hg).
  • History of ischemic heart disease, arrhythmias, QT prolongation, or risk factors for torsade de pointes.
  • Serious gastrointestinal disorders requiring surgery.
  • Having a pacemaker.
  • PET or CT scan within the past year.
  • Contraindications to stopping statins for 3 months or metformin/anti-hypertensive drugs for 7 days.
  • Smoking more than 1 cigarette per day or drinking more than 2 alcoholic beverages daily.
  • Blood donation within 2 months prior to study.
  • History of or current very high cholesterol (fasting plasma cholesterol >7 mmol/l) or triglycerides (>6 mmol/l).

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Centre de recherche du CHUS

Sherbrooke, Quebec, Canada, J1H 5N4

Actively Recruiting

Loading map...

Research Team

F

Frédérique Frisch

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here